Clinical trial
Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients.
NCT06190132 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients.
- Lead sponsor
- Ain Shams University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2023
- Completion date
- July 30, 2023
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
uremic pruritus in hemodialysis patients